BCDEFGHIJKLMNOPQRSTUVWXYZAA
1
LogIDTitle Initial Date
2
AK001Codebook for GA341 (= YJC AE538 = YMU RNA-seq on OKB2/S1F/THP1)SFL10/21/15
3
AK002Experimental sheme for AE592 (YMU RNA-seq GA416 and GA417)SFL10/23/15
27
AK026KSP Exp NotesSFLLink to KSP Exp Notes
28
AK027LRH_AKT 18 samples_Tools_NovagenSFL10/25/18
29
AK028YSL_37T_metaplastic BrCA_3 samplesSFL01/19/19
30
AK029YSL_mBrCA_5 samplesSFL05/13/19
31
AK030Tzu-Chi JWL_OrCA_PDX_5 samplesSFL05/20/19
32
AK031NGS data analysis of OC3 and TW2.6 CDX_12 samplesSFL04/22/19Link to Report
33
AK032Dr. Su YW PTEN KO – BD RhapsodySFL07/05/22
99
AK0980SFL
100
AK0990SFL
101
AK1000SFL
102
AE700Immunofluorescence assay for HP1gamma in dox-treated 293TetER (Trial1)YLC04/23/14
103
AE701Immunofluorescence assay for HP1beta/gamma in dox-treated 293TetERYLC05/06/14
104
AE702Test the fix condition of Immunofluorescence assayYLC05/06/14
105
AE703Immunofluorescence assay for p-gH2AX(S139) in dox-treated 293TetER (Trial1)YLC05/15/14
106
AE704Immunofluorescence assay for p-gH2AX(S139) in dox-treated 293TetER (Trial2)YLC05/20/14
107
AE705Immunofluorescence assay for p-gH2AX(S139) in 293TetER and OEC-M1YLC05/24/14
108
AE706Immunofluorescence assay for HP1gamma in dox-treated 293TetER (Trial2)YLC05/28/14
109
AE707Immunofluorescence assay of p-gH2AX(S139) and SA-beta-Gal staining in dox-treated 293TetER cellsYLC05/26/14
110
AE708Immunofluorescence assay of HP1gamma and SA-beta-Gal staining in dox-treated 293TetER cellsYLC05/26/14
111
AE709Immunofluorescence assay of FGFR3 on C9 and OEC-M1 (B9) (Trial1)YLC06/17/14
112
AE710Western blotting of abcam ab10651 anti-FGFR3 antibody on C9 and TW2.6 (Trial 1)YLC06/26/14
113
AE711Immunofluorescence of FGFR3 on C9 and TW2.6 (B9) (Trial2)YLC06/30/14
114
AE712Immunohistochemistry staining of FGFR3 (B9 and ab10651)YLC07/02/14
115
AE713Immunohistochemistry staining of FGFR3 (B9) in tissue microarray oral2089TYLC07/08/14
116
AE714Immunohistochemistry staining of FGFR3 (B9 and ab10651) in C9 and TW2.6YLC07/14/14
117
AE715Immunohistochemistry staining of FGFR3 (B9:sc13121) in C9 and TW2.6YLC07/28/14
118
AE716Immunohistochemistry staining of FGFR3 in Oral and Bladder tissue microarrayYLC08/18/14
119
AE717Western blotting of abcam ab10651 anti-FGFR3 antibody on C9 and TW2.6 (Trial 2)YLC08/20/14
120
AE718Cell block of C9 and TW2.6 cells (Trial 2)YLC08/05/14
121
AE719Cell block of 293, U937 and THP-1 cellsYLC09/09/14
122
AE720Western blotting of FGFR2 with sc-20735 and ab10648YLC09/18/14
123
AE721Immunofluorescence of FGFR2 on U937, THP-1 and 293 (Trial1)YLC10/07/14
124
AE722Immunofluorescence of FGFR2(sc20735) on U937, THP-1, 293 and C9 (Trial2)YLC10/15/14
125
AE723Immunofluorescence of FGFR2(sc20735) on U937, THP-1, 293 and C9 (Trial3)YLC10/22/14
126
AE724Immunohistochemistry staining of FGFR2 in LV2081 and LV8011 tissue microarrayYLC11/05/14
127
AE725Western blotting of AE532YLC11/19/14
128
AE726Weatern blotting of AE533YLC11/19/14
129
AE727To check the expression of EAD in CTCF over-expression cellsYLC12/10/14
130
AE728To check the expression of EAD in CTCF knock down cellsYLC12/15/14
131
AE729To check the expression of CTCF in dox-treated 293TetLuc, 293TetER, EREV8, ERKV cells YLC12/19/14
132
AE730Immunohistochemistry staining of FGFR3 (B9:sc13121) in C9 and TW2.6YLC/YHL12/29/14
133
AE731To check the expression of CTCF in dox-treated 293TetLuc, 293TetER cellsYLC01/26/15
134
AE732To check the expression of CTCF in dox-treated EREV8 cellsYLC02/26/15
135
AE733Protocol: Double-strand DNA synthesis (before seq library prep) from DR and YMWYLC03/05/15
136
AE734Related products of AE733YLC03/19/15
137
AE735To check the expression of CTCF in dox-treated EREV8, ERKV cells YLC05/25/15
138
AE736To test the cell number of 293TetLuc/ER in 96-well plateYLC05/27/15
139
AE737Compensation of DDR1 in DDR1-depleted OEC-M1 cellsYLC06/21/15
140
AE738To scan the DDR1/Col1/Col4 IHC slides by Mirax Scan (Taiwan Mouse Clinic) YLC07/06/15
141
AE739Aliquot TLCN#94 samples (90 T/N DNA and 48 T RNA)YLC07/28/15
142
AE740To test the immunofluorescence condition of 8-OHdG in H2O2 treated-293TetER cells (Trial 1)YLC08/05/15
143
AE741To test the immunofluorescence condition of 8-OHdG in H2O2 treated-293TetER cells (Trial 2)YLC08/11/15
144
AE742Immunofluorescence assay of 8-OHdG in AC-treated keratinocytesYLC08/13/15
145
AE743Immunofluorescence assay of 8-OHdG and p-gH2AX(S139) in H2O2 or bleomycin treated-293TetER cells (Trial 1)YLC08/21/15
146
AE744Immunoprecipitation of DDR1 in OEC-M1 cells (Trial 1)YLC09/02/15
147
AE745Immunoprecipitation of DDR1 in OEC-M1 cells (Trial 2)YLC09/07/15
148
AE746Immunofluorescence assay of 8-OHdG and p-gH2AX(S139) in H2O2 or bleomycin treated OEC-M1 cellsYLC09/07/15
149
AE747Immunofluorescence assay of 8-OHdG and p-gH2AX(S139) in H2O2 or bleomycin treated-293TetER cells (Trial 1)YLC09/10/15
150
AE748The anti-proliferation assay of Dasatinib, Imatinib and DDR1-IN-1 in OSCC, T-47D, and K6 cells (Trial 1)YLC10/08/15
151
AE749Immunofluorescence assay of 8-OHdG and p-gH2AX(S139) in H2O2 or bleomycin treated-293TetER cells (Trial 2)YLC10/07/15
152
AE750The anti-proliferation assay of Dasatinib, Imatinib and DDR1-IN-1 in OSCC, T-47D, and K6 cells (Trial 2)YLC10/15/15
153
AE751Shipping 8 gDNA samples to Dr Jeffrey Shu-Ming Chang LabYLC10/27/15
154
AE752The anti-proliferation assay of Dasatinib, Imatinib and DDR1-IN-1 in OSCC, T-47D, and K6 cells (Trial 3)YLC11/02/15
155
AE753Clonogenic survival assay of DDR1-IN1 treated T-47D and OSCC cellsYLC11/02/15
156
AE754The DDR1 expression level in 4OSCC, T47D and K6 cellsYLC11/04/15
157
AE755To check mycoplasma contamination in OEC-M1YLC11/09/15
158
AE756Clonogenic survival assay of DDR1-IN1 treated T-47D and OSCC cells (Trial 2)YLC11/16/15
159
AE757Immunofluorescence assay of p-MLC(Ser19) in DDR1-In-1 treated-TW2.6 and A431 (Trial 1)YLC11/23/15
160
AE758Clonogenic survival assay of DDR1-IN1 treated T-47D and OSCC cells (Trial 3)YLC11/23/15
161
AE759Prepare TW2.6 cells to Fu Huei for huMice xenograft ModelYLC11/19/15https://goo.gl/Lg3sR
162
AE760Clonogenic survival assay of DDR1-IN1 treated T-47D and OSCC cells (Trial 4)YLC11/30/15
163
AE761Harvest DDR1-IN-1 treated OC3, TW2.6 cellsYLC12/07/15
164
AE762Tissue processing, embedding, HE stain & blank section of AE759 (#14, #15)YLC12/10/15
165
AE763Immunofluorescence assay of E-caherin in DDR1-IN-1 treated-TW2.6 cells (Vol10, p53)YLC12/13/15
166
AE764Immunofluorescence assay of p-MLC(Ser19) in DDR1-IN-1 treated-TW2.6 cells (Vol10, p59)YLC12/15/15
167
AE765To check mycoplasma contamination after Plasmocin treatment in OEC-M1YLC12/16/15
168
AE766Tissue processing, embedding, HE stain & blank section of AE759 (#04, #10)YLC12/18/15
169
AE767Immunofluorescence assay of p-MLC(Ser19) in DDR1-IN-1 treated-A431, cGHNC9 cellsYLC12/22/15
170
AE768Tissue processing, embedding, HE stain & blank section of AE759 (#11, #13)YLC12/25/15
171
AE769Immunofluorescence assay of p-MLC(Ser19) in DDR1-IN-1 treated-A431, OEC-M1 cellsYLC12/26/15
172
AE770Immunofluorescence assay of E-caherin in DDR1-IN-1 treated-A431, cGHNC9 cellsYLC12/26/15
173
AE771To check mycoplasma contamination after Plasmocin treatment in OEC-M1 (Trial2)YLC12/28/15
174
AE772Immunofluorescence assay of p-MLC(Ser19) in DDR1-IN-1 treated-TW2.6 and A431 cellsYLC01/05/16
175
AE773Immunofluorescence assay of E-caherin in DDR1-IN-1 treated-TW2.6 and A431 cellsYLC01/05/16
176
AE774Blank section of OSCC from NCKU Dr. 蕭振仁 YLC01/13/16
177
AE775Immunofluorescence assay of p-MLC(Ser19) in DDR1-IN-1 treated-A431 cellsYLC01/18/16
178
AE776Immunofluorescence assay of E-caherin in DDR1-IN-1 treated-cGHNC9, OEC-M1 and TW2.6 cellsYLC01/18/16
179
AE777Tissue processing, embedding, HE stain & blank section of AE656 (PBS#26, TW2.6#11, OC3#14)YLC01/19/16
180
AE778Slide scan of AE759YLC01/21/16
181
AE779Immunofluorescence assay of E-caherin in DDR1-IN-1 treated-cGHNC9, OEC-M1 and A431 cells (Trial2)YLC01/26/16
182
AE780Immunohistochemistry staining of FGFR2 in TLCN (#1-6)YLC02/16/16
183
AE781Immunohistochemistry staining of FGFR2 in TLCN (#3, 7-14)YLC02/18/16
184
AE782Immunohistochemistry staining of FGFR2 in TLCN (#1, 2, 4-6, 15-48)YLC02/25/16
185
AE783Tissue processing, embedding, HE stain & blank section of AE656 (TW2.6-PBS#4, OC3-PBS#5, TW2.6#12, TW2.6#21, OC3#13)YLC02/02/16
186
AE784To detect the DNMT1, DNMT3a and DNMT3b expression in Dox-treated 293TetER cells by WBYLC03/02/16
187
AE785Slide scan of AE656YLC03/10/16
188
AE786Slide scan of AE781, AE782 (IHC of FGFR2 in TLCN)YLC03/10/16